Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 18/20 | 0.73 |
| ▸ | PPARD | Q03181 | 7/20 | 0.73 |
| ▸ | PPARG | P37231 | 2/20 | 0.73 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2069624 | 1.00 | PPARA (0.73) | PPARAPPARDPPARGCHRM4SMN1; SMN2 | |
| SCHEMBL2071212 | 1.00 | PPARA (0.73) | PPARAPPARDPPARGCHRM4SMN1; SMN2 | |
| SCHEMBL27678409 | 0.94 | PPARA (0.73) | PPARAPPARDPPARGCHRM4SMN1; SMN2 | |
| SCHEMBL2069705 | 0.89 | PPARA (0.58) | PPARAPPARDPPARG | |
| SCHEMBL2069703 | 0.89 | PPARA (0.58) | PPARAPPARDPPARG | |
| SCHEMBL2070736 | 0.88 | PPARA (0.66) | PPARAPPARDPPARGCHRM4SMN1; SMN2 | |
| SCHEMBL27706276 | 0.86 | PPARA (0.85) | PPARAPPARDPPARGCHRM4 | |
| SCHEMBL2069456 | 0.86 | PPARA (0.68) | PPARAPPARDPPARGCHRM4SMN1; SMN2 | |
| SCHEMBL14796948 | 0.85 | PPARA (0.56) | PPARAPPARDPPARG | |
| SCHEMBL2069537 | 0.84 | PPARA (1.00) | PPARAPPARDPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902367-B2 | Cyclic amino benzoic acid derivative | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20070249580-A1 | Novel Cyclic Amino Benzoic Acid Derivative | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2007-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249580-A1 | Novel Cyclic Amino Benzoic Acid Derivative | PPARA, PPARG, PPARD | PPARA 1/4885PPARD 3/4885PPARG 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.